A phase I trial of SAR650984, a CD38 monoclonal antibody, in relapsed or refractory multiple myeloma.
Thomas G. Martin
No relevant relationships to disclose
Karl Hsu
Employment or Leadership Position - Sanofi
Stephen Anthony Strickland
No relevant relationships to disclose
Martha Jane Glenn
No relevant relationships to disclose
Joseph Mikhael
Research Funding - Celgene; Onyx; Sanofi
Eric Charpentier
Employment or Leadership Position - Sanofi